久久久久久免费播放,求黄网站,东京一本到熟无码影音先锋

規(guī)格	庫(kù)存	目錄價(jià)	會(huì)員專(zhuān)享價(jià)	數(shù)量
5 mg	3-5days	￥400.00	登錄后可見(jiàn)	- +
10 mg	3-5days	￥650.00	登錄后可見(jiàn)	- +

規(guī)格

庫(kù)存

目錄價(jià)

會(huì)員專(zhuān)享價(jià)

數(shù)量

5 mg

3-5days

￥400.00

登錄后可見(jiàn)

- +

10 mg

3-5days

￥650.00

登錄后可見(jiàn)

- +

基本信息

英文名稱(chēng)	Elagolix Sodium; NBI 56418NA; NBI-56418 sodium
中文名稱(chēng)	噁拉戈利鈉
CAS號(hào)	832720-36-2
分子式	C32H29F5N3NaO5
分子量	653.57
外觀(guān)	White to light yellow powder
儲(chǔ)存條件	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

產(chǎn)品詳情

Elagolix sodium (NBI56418; ABT-620; Orilissa), the sodium salt of Elagolix, is an orally bioavailable and small molecule antagonist of the gonadotropin-releasing hormone receptor (GnRHR) (KD = 54 pM) approved on 7/23/2018 by FDA for the management of moderate to severe pain associated with endometriosis. Elagolix is a short-acting GnRH antagonist that suppresses ovarian estrogen production in a dose-dependent manner, meaning that higher doses result in full suppression while lower doses only cause partial suppression. Elagolix's non-peptide structure and oral bioavailability make it the leader of a new class of GnRH inhibitors known as second-generation inhibitors.

相關(guān)文獻(xiàn)

抱歉，暫時(shí)沒(méi)有相關(guān)文獻(xiàn)

相關(guān)產(chǎn)品

抱歉，暫時(shí)沒(méi)有相關(guān)產(chǎn)品

瀏覽記錄

CL2564A

噁拉戈利鈉

832720-36-2 98+% 3-5days

￥400.00 5 mg

成年人黄色毛片,四虎影在线永久免费四虎地址8848aa ,337p西西人体大胆瓣开下部,99久久99久久精品免观看,厨房里摸着乳丰满大屁股,视频一区二区欧美性爱

噁拉戈利鈉

Elagolix Sodium; NBI 56418NA; NBI-56418 sodium

化學(xué)品安全說(shuō)明書(shū)(MSDS)